Ultrasound-Triggered Microbubbles Plus Antibiotics for Knee Infections after Joint Replacement
Official title: Using Ultrasound and Microbubbles to Augment Antibiotic Efficiency Against Periprosthetic Joint Infections
Run by Thomas Jefferson University · NCT07599865 · Data updated 2026-11-12
This study tests whether adding ultrasound-activated microbubbles with antibiotics to the standard revision surgery for knee infections can lower re-infection rates.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Thomas Jefferson University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 3 sites (Philadelphia, Pennsylvania and 2 other locations) |
| Status | Recruiting |
| Started | August 13, 2026 |
| Main results expected | June 1, 2029 |
| Study ends | June 1, 2030 |
| Registry record updated | September 23, 2026 |
| Trial ID | NCT07599865 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 and older scheduled for knee revision surgery due to periprosthetic joint infection and who are medically stable.
✕Probably not a fit
Patients who do not respond to the microbubble therapy or who have contraindications to ultrasound-destructible agents may not see benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In people with an infected knee replacement, participants are randomly assigned to receive the standard surgical treatment with or without an additional ultrasound-activated microbubble therapy and antibiotics within 24 hours of revision. The primary goal is to see if this combination reduces re-infection by at least 24% compared with standard care alone. The trial uses a Phase 2 design to evaluate safety and preliminary effectiveness. Participants must meet specific surgical and health criteria and come from several U.S. centers partnered with Thomas Jefferson University and NIAID.
Why it matters
Potential benefit: If successful, patients may experience fewer reinfections after knee replacement surgery.
How similar studies have gone: This approach is exploratory; prior studies in similar areas have shown potential but results in this exact combination are not yet established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be at least 18 years of age * Be medically stable * If female of child-bearing potential, must have a negative pregnancy test * Be conscious and able to comply with study procedures * Have read and signed the IRB-approved Informed Consent form for participating in the study * For Cohort 1, be scheduled for one- or two-stage exchange arthroplasty revision surgery for PJI of the knee * For Cohort 2, be scheduled for DAIR revision surgery for PJI of the knee Exclusion Criteria: * Females who are pregnant or nursing * Patients currently on chemotherapy requiring systemic infusion treatment * Patients who are medically unstable, patients who are seriously or terminally ill, and patients whose clinical course is unpredictable * Patients with a history of anaphylactic allergy to perflutren or any other components of Definity * Patients with a history of failed one- or two-stage revision for infection * Patients for which placement of a surgical drain is contraindicated * Patients in protected classes (e.g., prisoners)
Where it's running
-
Thomas Jefferson University/Rothman Institute
Philadelphia, Pennsylvania, United States Recruiting -
University of Pittsburgh Medical Center (UPMC)
Pittsburgh, Pennsylvania, United States Not yet recruiting -
UT Southwestern Medical Center
Dallas, Texas, United States Not yet recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Periprosthetic Joint Infection After Hip or Knee Replacement: Causes and Prevention
This study tests whether certain factors before and after hip or knee replacement help predict and prevent peri-implant infections in adults 45 and older.
-
Finasteride and skin bacteria before shoulder surgery
This study tests whether taking finasteride for two weeks can lower skin testosterone and reduce Cutibacterium acnes on the skin of adult men.
-
Evaluating TNP-2092 for treating joint infections after knee surgery
This study is testing a new treatment called TNP-2092 to see if it can help people with joint infections after knee surgery feel better compared to the standard antibiotic treatment.
-
Identifying pathogens in joint infections using advanced molecular techniques
This study is testing a new method called Multiplex PCR to see if it can better identify germs causing joint infections compared to the usual lab tests.
-
TNP-2092 injection for knee prosthetic joint infection
This study tests TNP-2092 injected into the joint to see if it helps treat knee prosthetic joint infection in adults already receiving antibiotics.
-
Biomarkers for Prosthetic Infection Detection using Nanopore Sequencing
This study tests new biomarkers to rapidly detect prosthetic joint infection in people having hip or knee revision surgery using nanopore sequencing.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.